Nicholas Raccagni: Heparin for VTE Prevention After Traumatic Brain Injury
Nicholas Raccagni, Biomedical Research Trainee at Virgilio Program, Neurosurgery Internship at Fondazione IRCCS Istituto Neurologico Carlo Besta (Milan, Italy), shared a post on LinkedIn about a recent article he and his colleges co-authored, published in Neurosurgery, adding:
“Venous thromboembolism prophylaxis after traumatic brain injury sits at the intersection of thrombosis prevention and hemorrhagic risk.
In our recent article in Neurosurgery, we compared low-molecular-weight heparin and unfractionated heparin in adults with TBI, synthesizing the available direct comparative evidence and examining the consistency of observed associations across TBI phenotypes.
Our findings point to a clinically relevant signal, but one that remains difficult to disentangle from treatment selection and residual confounding present within the entirely retrospective evidence base.
Prospective studies are needed to determine whether this signal is causal and how it should inform thromboprophylaxis in TBI.
I am especially grateful to Leonardo Di Cosmo and Ismail Zaed for their close collaboration throughout this project, and to all my co-authors for their contributions.”
Title: Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Adult Traumatic Brain Injury: A Systematic Review and Meta-Analysis
Authors: Nicholas Giulio Raccagni, Leonardo Di Cosmo, Marco Dotti, Filippo Emanuele Colella, Sofia Carmelini, Ismail Zaed
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 12, 2026, 16:35Mohamed Hesham Gamal: Intravenous Thrombolysis Shows Strong Safety Profile in Stroke Mimics
-
Nov 12, 2026, 14:35Mokhtar Tazik: Connecting Clinical Demand with Plasma Collection and Fractionation Capacity
-
Nov 12, 2026, 14:25Kim Phelan: Celebrating Dr. Marilyn Manco-Johnson as a Recipient of the 2026 Eternal Spirit Award
-
Nov 12, 2026, 14:20Shailesh Kucha: Ensuring Transfusion Safety Through Biochemical Assessment of Stored Red Cells
-
Nov 12, 2026, 14:20Akshat Jain: Wonderful Time Presenting at the ATHN 2026
-
Nov 12, 2026, 14:08Elisa Gabinaud: The Evolving Science of Megakaryocyte Development
-
Nov 12, 2026, 13:57Seyed Mohammad Sadegh Pezeshki: When Microcytosis Reveals a Complex Hemoglobinopathy
-
Nov 12, 2026, 13:45Danny Hsu: THANZ Highlights Antiphospholipid Syndrome in Upcoming Educational Webinar
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH